110 related articles for article (PubMed ID: 33082275)
1. HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
Qiu Y; Maione F; Capano S; Meda C; Picconi O; Brundu S; Pisacane A; Sapino A; Palladino C; Barillari G; Monini P; Bussolino F; Ensoli B; Sgadari C; Giraudo E
Mol Cancer Ther; 2020 Dec; 19(12):2476-2489. PubMed ID: 33082275
[TBL] [Abstract][Full Text] [Related]
2. Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity.
Barillari G; Iovane A; Bacigalupo I; Palladino C; Bellino S; Leone P; Monini P; Ensoli B
AIDS; 2012 May; 26(8):909-19. PubMed ID: 22313963
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antitumoral properties of the protease inhibitor indinavir in a murine model of hepatocarcinoma.
Esposito V; Palescandolo E; Spugnini EP; Montesarchio V; De Luca A; Cardillo I; Cortese G; Baldi A; Chirianni A
Clin Cancer Res; 2006 Apr; 12(8):2634-9. PubMed ID: 16638877
[TBL] [Abstract][Full Text] [Related]
4. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.
Barillari G; Monini P; Sgadari C; Ensoli B
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747434
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.
Toschi E; Sgadari C; Malavasi L; Bacigalupo I; Chiozzini C; Carlei D; Compagnoni D; Bellino S; Bugarini R; Falchi M; Palladino C; Leone P; Barillari G; Monini P; Ensoli B
Int J Cancer; 2011 Jan; 128(1):82-93. PubMed ID: 20617515
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E
Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993
[TBL] [Abstract][Full Text] [Related]
8. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.
Giraudo E; Inoue M; Hanahan D
J Clin Invest; 2004 Sep; 114(5):623-33. PubMed ID: 15343380
[TBL] [Abstract][Full Text] [Related]
9. Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
Hampson L; Kitchener HC; Hampson IN
Antivir Ther; 2006; 11(6):813-25. PubMed ID: 17310826
[TBL] [Abstract][Full Text] [Related]
10. [Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].
Solov'eva NI; Timoshenko OS; Kugaevskaia EV; Andreeva IuIu; Zavalishina LE
Bioorg Khim; 2014; 40(6):743-51. PubMed ID: 25895371
[TBL] [Abstract][Full Text] [Related]
11. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Ryzhakova OS; Solov'eva NI
Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
[TBL] [Abstract][Full Text] [Related]
12. Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis.
Yang J; Chen S; Huang X; Han J; Wang Q; Shi D; Cheng R; Gao G; Yang X
Cancer Biol Ther; 2010 Jun; 9(12):967-74. PubMed ID: 20364117
[TBL] [Abstract][Full Text] [Related]
13. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Zhu D; Ye M; Zhang W
Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
[TBL] [Abstract][Full Text] [Related]
14. Raman chemical mapping reveals site of action of HIV protease inhibitors in HPV16 E6 expressing cervical carcinoma cells.
Kim DH; Jarvis RM; Allwood JW; Batman G; Moore RE; Marsden-Edwards E; Hampson L; Hampson IN; Goodacre R
Anal Bioanal Chem; 2010 Dec; 398(7-8):3051-61. PubMed ID: 20957472
[TBL] [Abstract][Full Text] [Related]
15. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
Sgadari C; Barillari G; Toschi E; Carlei D; Bacigalupo I; Baccarini S; Palladino C; Leone P; Bugarini R; Malavasi L; Cafaro A; Falchi M; Valdembri D; Rezza G; Bussolino F; Monini P; Ensoli B
Nat Med; 2002 Mar; 8(3):225-32. PubMed ID: 11875492
[TBL] [Abstract][Full Text] [Related]
16. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
17. Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence.
da Silva Cardeal LB; Brohem CA; Corrêa TC; Winnischofer SM; Nakano F; Boccardo E; Villa LL; Sogayar MC; Maria-Engler SS
Biochem Cell Biol; 2006 Oct; 84(5):713-9. PubMed ID: 17167534
[TBL] [Abstract][Full Text] [Related]
18. Reduction of Adipose Tissue Mass by the Angiogenesis Inhibitor ALS-L1023 from Melissa officinalis.
Park BY; Lee H; Woo S; Yoon M; Kim J; Hong Y; Lee HS; Park EK; Hahm JC; Kim JW; Shin SS; Kim MY; Yoon M
PLoS One; 2015; 10(11):e0141612. PubMed ID: 26599360
[TBL] [Abstract][Full Text] [Related]
19. Praeruptorin A Inhibits Human Cervical Cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling.
Wu MH; Lin CL; Chiou HL; Yang SF; Lin CY; Liu CJ; Hsieh YH
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267213
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 expression.
Hussain A; Harish G; Prabhu SA; Mohsin J; Khan MA; Rizvi TA; Sharma C
Cancer Epidemiol; 2012 Dec; 36(6):e387-93. PubMed ID: 22884883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
